Skip to content
★ Sign in to follow
동

동구바이오제약

Related company / holding
Insider activity · 24 months1 buy2 salesCumulative net flow
Total declarations
67
Company
1
▲ Purchases (6 ops.)
—
▼ Sales (2 ops.)
—

Latest filing published 05 Nov 2026 for 큐리언트.

Filing timeline

BuySale
동구바이오제약

Insider track record

Disclosed buys
6
Disclosed sells
2
Signal history

No signal scores available.

Closed purchases

Market purchases
6

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Since each purchase

  • Filed 26 Feb 2026 · 256 days ago · €9.8M
    -50.9%
    Entry ₩32,250 · Close 03 Nov 2026 ₩15,840
  • Filed 29 Nov 2024 · 710 days ago · €4.9M
    +585.7%
    Entry ₩4,550 · Close at T+365 ₩31,200
  • Filed 05 Aug 2024 · 826 days ago · €5.6M
    +182.6%
    Entry ₩4,395 · Close at T+365 ₩12,420

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

동구바이오제약: trading record in brief

동구바이오제약 appears in our data through filings on 큐리언트 shares, published by DART (FSS). In total, 67 filings cover trades dated from 4 May 2021 to 5 November 2026.

Both buying and selling appear: 6 purchases, against 2 sales. The totals exclude 8 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 1 purchase and 2 sales on the market.

No cluster: in 4 purchases, no other insider of the company bought within 30 days.

On 5 November 2026 came the latest disclosure, a transaction in 큐리언트. The last insider purchase was made public on 26 February 2026, 256 days ago. The median gap between a trade and its publication by DART (FSS) is 4 days. This delay matters because a trade only becomes useful information once it is public. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Companies and markets linked to 동구바이오제약

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations67 total

25 of 67 declarations